Functionally inactivating point mutation in the tumor-suppressorIRF-1 gene identified in human gastric cancer
Open Access
- 12 August 1998
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 77 (4) , 522-527
- https://doi.org/10.1002/(sici)1097-0215(19980812)77:4<522::aid-ijc8>3.0.co;2-w
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Identification and characterization of nucleophosmin/B23/numatrin which binds the anti-oncogenic transcription factor IRF-1 and manifests oncogenic activityOncogene, 1997
- Phosphorylation Events Modulate the Ability of Interferon Consensus Sequence Binding Protein to Interact with Interferon Regulatory Factors and to Bind DNAJournal of Biological Chemistry, 1997
- An IRF-1-dependent pathway of DNA damage-induced apoptosis in mitogen-activated T lymphocytesNature, 1995
- Genetic alterations in human gastrointestinal cancers. The application to molecular diagnosisCancer, 1995
- Production of high-titer helper-free retroviruses by transient transfection.Proceedings of the National Academy of Sciences, 1993
- Chromosome Aberrations and CancerScience, 1991
- Molecular themes in oncogenesisCell, 1991
- Absence of the type I IFN system in EC cells: Transcriptional activator (IRF-1) and repressor (IRF-2) genes are developmentally regulatedCell, 1990
- Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell lineNucleic Acids Research, 1990
- Mutation and Cancer: Statistical Study of RetinoblastomaProceedings of the National Academy of Sciences, 1971